MedRhythms, Edwards Health Care Services Enter into Distribution Agreement

PORTLAND, Maine—MedRhythms, Inc., a provider of neurologic and physical rehabilitation, announced its partnership with Edwards Health Care Services (EHCS), a provider of direct-to-home medical products. The partnership will enable nationwide distribution of MedRhythms’ currently available devices, InTandem, for adults with chronic stroke walking impairments and MOVIVE for people with Parkinson’s disease (PD), to patients with Medicare and/or commercial insurance.

InTandem and MOVIVE use music to deliver rythmic auditory stimulation (RAS), a clinically proven neurorehabilitation intervention backed by more than 30 years of research. In a multi-site randomized controlled trial published in the journal Nature Communications, InTandem users experienced statistically significant and clinically meaningful gains in walking speed and were over three times more likely to respond on average, versus active control. In a feasibility study, MOVIVE was able to improve gait quality and facilitate moderate intensity gait training for PD participants.

The EHCS distribution partnership builds on MedRhythms’ national reimbursement infrastructure, following recent Center for Medicare and Medicaid Services (CMS) decisions to establish a health care common procedure coding system (HCPCS) code (E3200), finalize the CMS payment determination for the code and confirm the benefit category as durable medical equipment (DME) for gait modulation systems that use RAS. This new distribution partnership extends those access pathways to patients with Medicare or private insurance.

“At Edwards Health Care Services, we are committed to improving access to innovative therapies that help people live healthier, more independent lives,” said Matthew Edwards, CEO of EHCS. “Through this partnership with MedRhythms, we can deliver proven neurorehabilitation solutions directly to patients’ homes, supporting better mobility and quality of life for those managing stroke recovery and Parkinson’s disease.”

“Our partnership with EHCS is a consequential milestone in MedRhythms’ growth trajectory,” said Larry Jasinski, Chief Executive Officer of MedRhythms. “It enhances our ability to scale nationally, strengthens our commercial infrastructure, and advances our mission to improve the lives of people with neurologic diseases. With expanded access through commercial insurance, Medicare, and VA coverage, MedRhythms is positioned to drive meaningful clinical impact while building a strong business in a large and growing market.”